Abstract
The majority of familial Alzheimer’s disease (AD) cases are linked to mutations of the presenilin 1 and 2 (PS1, PS2) genes on chromosomes 14 and 1, respectively (1-3). PS1 and PS2 are about 67% identical in amino acid sequence. Based on hydrophobicity analysis, the presenilins are predicted to have multiple transmembrane domains. Structural analysis (see Chapter 19}) suggest that presenilins are 6-8 transmembrane proteins which are located in the endoplasmic reticulum (ER) and Golgi. The N- and C-termini and the large hydrophilic loop region are oriented to the cytoplasm (4,5). More than 40 AD-causing mutations have been identified in PS1, whereas only two mutations have been identified in PS2. The disease-causing mutations span most domains of the protein, with clusters of mutations in the second transmembrane domain and the large hydrophilic loop region Fig. 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375, 754–760.
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., et al. (1995) Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 269, 973–977.
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., et al. (1995) Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s type 3 gene. Nature 376, 775–778.
Doan, A., Thinakaran, G., Borchelt, D. R., Slunt, H. H., Ratovski, T., Podlisny, M., et al. (1996) Protein topology of presenilin 1. Neuron 17, 1023–1030.
Li, X. and Greenwald, I. (1996) Membrane topology of the C. elegans SEL-12 presenilin. Neuron 17, 1015–1021.
Busciglio, J., Hartmann, H., Lorenzo, A., Wong, C, Baumann, K.-H., Sommer, B., et al. (1997) Neuronal localization of presenilin 1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer’s disease. J. Neurosci. 17, 5101–5107.
Thinakaran, G., Borchelt, D. R., Lee, M. K., Ratovski, T., Davenport, F., Nordstedt, C., et al. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181–190.
Mercken, M., Takahashi, H., Honda, T., Sato, K., Murayama, M., Nakazato, Y., et al. (1996) Characterization of human presenilin using N-terminal specific monoclonal antibodies: evidence that Alzheimer mutations affect proteolytic processing. FEBS Lett. 389, 297–303.
Kim, T.-W., Pettingell, W. H., Hallmark, O. G., Moir, R. D., Wasco, W., and Tanzi, R. E. (1997) Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J. Biol. Chem. 272, 11,006–11,010.
Thinakaran, G., Harris, C. L., Ratovitski, T., Davenport, F., Slunt, H. H., Price, D. L., et al. (1997) Evidence that levels of presenilins (PS 1 and PS2) are coordinately regulated by competition for limiting cellular factors. J. Biol. Chem. 272, 28,415–28,422.
Ratkovsi, T., Slunt, H. H., Thinakaran, G., Price, D. L., Sisodia, S. S., and Borchelt, D. R. (1997) Endoproteolytic processing and stabilization of wild-type and mutant presenilin. J. Biol. Chem. 272, 11,006–11,010.
Hartmann, H., Busciglio, J., and Yankner, B. A. (1998) Neuronal regulation of presenilin-1 processing, in Presenilins and Alzheimer’s Disease (Younkin, S. G., Tanzi, R. E., and Christen, Y., eds.), Foundation Ipsen, Springer-Verlag, Heidelberg, Germany, pp. 85–91.
Podlisny, M. B., Citron, M., Amarante, P., Sherrington, R. Xia, W., Zhang, J., et al. (1997) Neurobiol. Dis. 3, 325–337.
Shirotani, K., Takahashi, K., Ozawa, K., Kunishita, T., and Tabira, T. (1997) Determination of a cleavage site of presenilin 2 protein in stably transfected SH-S Y5 Y human neuroblastoma cell lines. Biochem. Biophys. Res. Commun. 240, 728–731.
Hartmann, H., Busciglio, J., Baumann, K.-H., Staufenbiel, M., and Yankner, B. A. (1997) Developmental regulation of presenilin-1 processing in the brain suggests a role in neuronal differentiation. J. Biol. Chem. 272, 14,505–14,508.
Capell, A., Saffrich, R., Olivo, J.-C., Meyn, L., Walter, J., Grünberg, J.,et al. (1997) Cellular expression and proteolytic processing of presenilin proteins is developmentally regulated during neuronal differentiation. J. Neurochem. 69, 2432–2440.
Hartmann, H., Busciglio, B., Zhang, Z., Baumann, K.-H., Staufenbiel, M., and Yankner, B. A. (1997) Developmental regulation of presenilin-1 cleavage in the brain. Soc. Neurosci. Abstr. 117, 6.
Murayama, O., Honda, T., Mercken, M., Murayama, M., Yasutake, K., Nihonmatsu, N., et al. (1997) Different effects of Alzheimer-associated mutations of presenilin-1 on ist processing. Neurosci. Lett. 229, 61–64.
Kim, T.-W., Pettingell, W. H., Jung, Y.-K., Kovacs, D., and Tanzi, R. E. (1997) Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277, 373–376.
Lee, M. K., Borchelt, D. R., Kim, G., Thinakaran, G., Slunt, H. H., Ratovitski, T., et al. (1997) Hyperaccumulation of FAD-linked presenilin-1 variants in vivo. Nat. Med. 3, 756–760.
Hartmann, H., Busciglio, J., Wong, C., Staufenbiel, M., and Yankner, B. A. (1996) Apoptosis and the Alzheimer’s disease gene presenilin-1. Soc. Neurosci. Abstr. 293.13.
Okochi, M., Ishii, K., Usami, M., Sahara, N., Kametani, F., Tanaka, K., et al. (1997) Proteolytic processing of presenilin-1 (PS1) is not associated with Alzheimer’s disease with or without PS 1-mutations. FEBS Lett. 418, 162–166.
Levey, A. I., Heilman, C. J., Lah, J. J., Nash, N. R., Rees, H. D., Wakai, M., et al. (1997) Presenilin-1 protein expression in familial and sporadic Alzheimer’s disease. Ann. Neurol. 41, 7742–753.
Levitan, D., Doyle, T. G., Brousseau, D., Lee, M. K., Thinakaran, G., Slunt, H. H., et al. (1996) Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 93, 14,940–14,944.
Baumeister, R., Leimer, U., Zweckbronner, I., Jakubek, C., Grünberg, J., and Haass, C. (1997) Human presenilin-1, but not familial Alzheimer’s disease (FAD) mutants, facilitate Caenorhabditis elegans notch signalling independently of proteolytic processing. Genes Funct. 1, 149–159.
Capell, A., Grünberg, J., Pesold, B., Diehlmann, A., Citron, M., Nixon, R., et al. (1998) The proteolytic fragments of the Alzheimer’s disease-associated presenilin-1 form heterodimers and occur as a 100-150 kD molecular mass complex. J. Biol. Chem. 273, 3205–3211.
Vito, P., Lacana, E., and D’Adamio, L. (1996) Interfering with apoptosis: Ca2+-binding protein ALG-2 and Alzheimer’s disease gene ALG-3. Science 271, 521–525.
Wolozin, B., Iwasaki, K., Vito, P., Ganjei, J. K., Lacana, E., Sunderland, T., Zhao, B., Kusiak, J. W., Wasco, W., and D’Adamio, L. (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710–1712.
Hardy, J. (1997) Amyloid, the presenilins and Alzheimer’s disease. Trends Neurosci. 20, 154–159.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Hartmann, H., Yankner, B.A. (2000). Normal Proteolytic Processing of the Presenilins. In: Hooper, N.M. (eds) Alzheimer's Disease. Methods in Molecular Medicine™, vol 32. Humana Press. https://doi.org/10.1385/1-59259-195-7:297
Download citation
DOI: https://doi.org/10.1385/1-59259-195-7:297
Publisher Name: Humana Press
Print ISBN: 978-0-89603-737-3
Online ISBN: 978-1-59259-195-4
eBook Packages: Springer Protocols